BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24762503)

  • 1. Dosimetric comparison of vaginal vault ovoid brachytherapy versus intensity-modulated radiation therapy plans in postoperative patients of cervical carcinoma following whole pelvic radiotherapy.
    Khosla D; Patel FD; Oinam AS; Tomar P; Sharma SC
    J Cancer Res Ther; 2014; 10(1):153-8. PubMed ID: 24762503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
    Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative dosimetric and radiobiological assessment among a nonstandard RapidArc, standard RapidArc, classical intensity-modulated radiotherapy, and 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecologic cancer.
    Pedicini P; Caivano R; Fiorentino A; Strigari L; Califano G; Barbieri V; Sanpaolo P; Castaldo G; Benassi M; Fusco V
    Med Dosim; 2012; 37(4):347-52. PubMed ID: 22382087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
    Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
    Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
    Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
    Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
    Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
    DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
    Aydogan B; Mundt AJ; Smith BD; Mell LK; Wang S; Sutton H; Roeske JC
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):266-73. PubMed ID: 16618581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose escalation by intensity-modulated radiotherapy boost after whole pelvic radiotherapy in postoperative patients of carcinoma cervix with residual disease.
    Khosla D; Patel FD; Rai B; Chakraborty S; Oinam AS; Sharma SC
    Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):e1-6. PubMed ID: 22889568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
    Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma.
    D'Souza WD; Ahamad AA; Iyer RB; Salehpour MR; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1062-70. PubMed ID: 15752885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial brachytherapy vs. intensity-modulated radiation therapy for patients with cervical carcinoma not suitable for intracavitary radiation therapy.
    Sharma DN; Gandhi AK; Sharma S; Rath GK; Jagadesan P; Julka PK
    Brachytherapy; 2013; 12(4):311-6. PubMed ID: 23466359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dosimetric planning study comparing intensity-modulated radiotherapy with four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma.
    Forrest J; Presutti J; Davidson M; Hamilton P; Kiss A; Thomas G
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):e63-70. PubMed ID: 21752614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
    Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
    Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
    Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
    Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.
    van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB; Both S; Ingram M; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
    Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
    Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage.
    Duan J; Kim RY; Elassal S; Lin HY; Shen S
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):765-71. PubMed ID: 18164832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.